KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Inventory (2016 - 2025)

Bausch Health Companies' Inventory history spans 17 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Inventory rose 2.13% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 2.13%, while the annual FY2025 figure was $1.6 billion, 2.13% up from the prior year.
  • Inventory for Q4 2025 was $1.6 billion at Bausch Health Companies, up from $1.6 billion in the prior quarter.
  • Across five years, Inventory topped out at $1.7 billion in Q3 2024 and bottomed at $993.0 million in Q4 2021.
  • The 5-year median for Inventory is $1.3 billion (2023), against an average of $1.3 billion.
  • The largest annual shift saw Inventory dropped 13.56% in 2021 before it soared 41.65% in 2023.
  • A 5-year view of Inventory shows it stood at $993.0 million in 2021, then increased by 9.77% to $1.1 billion in 2022, then skyrocketed by 41.65% to $1.5 billion in 2023, then grew by 3.3% to $1.6 billion in 2024, then rose by 2.13% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Inventory are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.7 billion (Q2 2025).